AMR Control 1
Tuesday 21 May 2024, 12:00-13:00 CET
Socioeconomic and sociocultural factors play a critical role in driving AMR, shaping its health and economic impacts, and influencing the effectiveness of innovations that seek to tackle it.
The emergence and spread of AMR relate to a mix of factors including gender, living situations, education, healthcare access, (poor) governance, mobility, conflict, climate change, agriculture and pollution. AMR policy that understands these factors and the way they interact will be more likely to work.
But what are the policy areas that matter most? How can we better understand the socioeconomic drivers of AMR? What does good governance look like? Join us to find out!
Speakers:
- Gunnar Ljungqvist (Georgetown University, USA)
- Esmita Charani (University of Cape Town, South Africa)
- Anthony McDonnell (Centre for Global Development, UK)
- Victoria Saint (University of Bielefeld, Germany)
- Danilo Lo Fo Wong (WHO Regional Office for Europe)
Moderators:
- Michael Anderson (University of Manchester/LSE) and Erica Richardson (European Observatory on Health Systems and Policies)
Observatory Webinar Spotlight Series: From evidence to practice in AMR prevention and control
Antimicrobial resistance (AMR) is a major global public health challenge. With resistance to second and third-line antimicrobials growing the threat is profound. But how can we leverage our knowledge of the drivers and impacts of AMR to enable its prevention and control?
This spotlight series consists of two webinars covering different aspects of AMR control:
- The socioeconomic drivers and impacts of AMR
- Strengthening the EU response to prevention and control of AMR
As part of our ongoing work on AMR in support of Presidencies of the Council of the EU we have explored how to address the significant health and economic impacts of antimicrobial resistance (AMR) on individuals, households, health systems and society. However, in seeking sustainable solutions, the socioeconomic and sociocultural drivers of AMR are often neglected. National and international commitments to a “One-Health” approach offer some hope and bring sectors, disciplines, and communities together but despite years of policy discussion and much agreement, action on AMR is slow. What should the EU and its Member States focus on to drive change?